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Abstract
Background and study aims: Magnifying endoscopy with narrow-band imaging (ME-NBI) is more reliable than
chromoendoscopy (CE) for delineating the horizontal extent of early gastric cancers prior to endoscopic
submucosal dissection (ESD). However, the added benefits of ME-NBI over CE in terms of the difference in
magnification level have yet to be elucidated. The aim of this study was to investigate the improvement in
diagnostic accuracy for tumor delineation obtained with different magnification levels of ME-NBI following CE.
Patients and methods: This was a retrospective study, performed at a single tertiary referral center. A series of 158
consecutive patients with 161 early gastric cancers resected en bloc using ESD was included in the study. The margins of
each lesion were examined in their entirety using CE, followed by low power optical magnifying endoscopy with
narrow-band imaging (LM-NBI), and finally the highest power optical magnifying endoscopy with narrow-band imaging
(HM-NBI). The primary endpoint was the added benefit, as measured using the successful delineation rate, for the
delineation of gastric cancer margins using CE + LM-NBI vs CE, and for CE + LM-NBI + HM-NBI vs CE + LM-NBI.
Results: The successful delineation rates (95 % CI) using CE, CE + LM-NBI and CE + LM-NBI + HM-NBI were 72.7 %
(68.5-79.9 %), 88.9 % (84.2-93.8 %), and 98.1 % (95.8-100 %). The diagnostic accuracy improved significantly for
CE + LM-NBI compared with CE (P < 0.001), and for HM-NBI compared with LM-NBI (P < 0.001).
Conclusions: HM-NBI is useful for improving diagnostic performance for endoscopic delineation of early
gastric cancers, following CE and LM-NBI.
Keywords: Chromoendoscopy, Demarcation line, Early gastric cancer, Magnifying endoscopy, Narrow-band
imaging
Background
On order to be curative, endoscopic submucosal dissec-
tion (ESD) of early gastric cancers requires accurate
determination of the horizontal extent of invasion so
that the lesion can be completely removed in one piece
[1]. In 2002, Yao et al. reported that magnifying endos-
copy (ME) is useful for delineating the margins of gastric
cancers [2]. The use of narrow-band imaging (NBI),
developed in 2006, in combination with ME allows
observation of the microvascular and microsurface pat-
terns in high contrast [3]. A number of studies have
since reported superior diagnostic ability for magnifying
endoscopy with narrow-band imaging (ME-NBI) over
conventional endoscopy in delineating the lateral extent
of early gastric neoplasias [3–8]. The authors already use
ME-NBI in the clinical setting for detection of the
margins of gastric cancers, and we reported that using
the maximal magnifying ration of the magnifying endo-
scope improves the diagnostic accuracy for delineation
of the margins of differentiated early gastric cancers that
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could not be delineated using chromoendoscopy (CE)
[4]. However, other studies have not reported the actual
magnifying ratio used when performing ME [5–8].
We hypothesized that utilization of the maximal
optical magnifying ratio during magnifying endoscopy
provides the best spatial resolution, and increases the
diagnostic ability to differentiate between cancerous and
non-cancerous mucosa. However, there have been no
published reports of the effect of different magnification
levels on the ability to delineate margins of early gastric
cancers when ME is added to CE using indigo carmine,
the latter widely used clinically up to the present. The
aims of this study were to determine the additive effect
for the delineation of the margins of early gastric can-
cers, following CE, of low power optical magnifying
endoscopy with NBI (LM-NBI) vs highest power optical
magnifying endoscopy with NBI (HM-NBI).
Patients and methods
Patients
All investigations were performed after subjects received
a thorough explanation, and provided their written
informed consent. This study was a retrospective study
and approved by the Ethic Committee of the Kochi Red
Cross Hospital.
Inclusion and exclusion criteria
Inclusion criteria
Consecutive patients with differentiated early gastric can-
cers, diagnosed endoscopically and assessed as suitable for
ESD, and resected using ESD between July 2008 and June
2012.
Exclusion criteria
Lesions that could not be adequately assessed histo-
pathologically, lesions that were not resected in one
piece, and lesions with a histopathological diagnosis of
undifferentiated carcinoma.
Methods
Examination using LM-NBI and HM-NBI
When performing ME of the upper gastrointestinal tract,
once a lesion is detected using non-magnifying white
light imaging (WLI), pressing the zoom lever on the
endoscope control section enables examination using
optical magnification. Pushing the lever down fully pro-
vides the highest power optical magnification. The focal
distance at the maximal magnifying ratio is 2 mm. We
defined the magnification level with a focal distance of
4 mm as low power optical magnification (LM).
To obtain this fixed LM, we made the following pre-
endoscopy preparations. We attached a disposable distal
attachment (D-201-11304, Olympus Medical Systems
Corp., Tokyo, Japan) to the tip of the upper gastrointestinal
endoscope (GIF-H260Z, Olympus Medical Systems Corp),
fixing the focal distance at 4 mm. Adjusting the focus, we
fixed a piece of white tape to indicate the position of the
upper edge of the zoom lever, so that during an endoscopy
we could depress the zoom lever to provide a consistent
level of magnification (Fig. 1a). The resolutions at
the low power magnification (LM) and highest power
magnification (HM) were 13.9 μm and 5.6 μm, respect-
ively (Fig. 1b, c).
Endoscopic procedures
All endoscopies were performed by the authors, specialist
endoscopists experienced with HM-NBI, using the GIF-
H260Z upper gastrointestinal endoscope with the EVIS
Lucera Spectrum system (Olympus Medical Systems Corp).
A soft black hood (MAJ1990, Olympus Medical Systems
Corp) was attached to the scope tip to obtain HM-NBI
images in focus. Each patient underwent sequential CE,
LM-NBI and HM-NBI examinations during the same pro-
cedure as preoperative diagnostic examinations 1 to 2 weeks
prior to ESD.
Chromoendoscopy (CE)
Following thorough lavage, the lesion was sprayed with
0.1 % indigo carmine, and the lesion margin was exam-
ined in its entirety using non-magnifying WLI.
Low power optical magnifying endoscopy with narrow-
band imaging (LM-NBI)
Following CE and thorough rinsing of indigo carmine
dye, we depressed the zoom lever as far as the previously
applied white tape, and examined the lesion margin in
its entirety using LM-NBI.
Highest power optical magnifying endoscopy with
narrow-band imaging (HM-NBI)
Following LM-NBI, we depressed the zoom lever fully
and examined the lesion margin in its entirety at the
highest power magnification.
When the demarcation line (DL) could not be delin-
eated in its entirety even using HM-NBI, we took a biopsy
from the lesion surrounds in an area showing definite
findings of non-cancerous mucosa, confirming that the
biopsy specimen contains no cancerous tissue, thereby de-
lineating the lesion margin over its entire circumference.
On the day of the ESD procedure, or the preceding
day, using HM-NBI we again identified the lesion mar-
gin, and made markings 3–5 mm outside the DL, and
then, made an incision 3–5 mm outside these markings.
Resected specimens were fixed in 10 % formalin solu-
tion. Following fixation, the specimen was sliced with
2 mm spacing, then stained for histological examination.
With reference to the pathohistological findings, we
identified the markings, and reconstructed the lateral
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extent of the cancer on the endoscopic image. The histo-
logically determined cancer margins were used as the
gold standard to evaluate the diagnostic accuracy for
CM, CE + LM-NBI, and CE + LM-NBI + HM-NBI ac-
cording to our previous study [4].
Diagnostic criteria for cancer specific margins
We defined the DL as determined using CE as the area
showing the two findings of “presence of a border between
the lesion and non-lesion mucosa” and “disappearance of
the gastric areas in the surrounding area at the border line”.
We used the VS (vessel plus surface) classification proposed
by Yao et al. for the definition of the DL as determined
using ME-NBI. This defines the cancer margin as having
the two findings of “a clear demarcation line where the
surrounding regular microvascular pattern and/or regular
microsurface pattern disappears” and “the presence of an
irregular microvascular pattern and/or irregular microsur-
face pattern within the demarcation line” [4, 9–12].
For each examination method, we defined the result as
“possible delineation”, “successful delineation” or “unsuc-
cessful delineation” as follows (Figs. 2 and 3).
Possible delineation: a DL can be delineated endoscop-
ically over the entire circumference of the lesion.
Possible delineation using CE: a DL can be delineated
over the entire circumference of the lesion using CE.
Possible delineation using CE + LM-NBI: a DL can be
delineated over the entire circumference of the lesion
for the first time using LM-NBI.
Possible delineation using CE + LM-NBI + HM-NBI: a
DL can be delineated over the entire circumference of
the lesion for the first time using HM-NBI.
Successful delineation and unsuccessful delineation:
defined as follows for each examination method as we
reported previously [4].
Successful delineation using CE: Possible delineation
using CE and, the same DL can also be delineated using
LM-NBI and HM-NBI, and histological examination
confirms the presence of cancer within the markings.
Successful delineation using CE + LM-NBI: Possible
delineation using CE + LM-NBI, and also using HM-
NBI, and histological examination confirms the presence
of cancer within the markings.
Successful delineation using CE + LM-NBI + HM-NBI:
Possible delineation using CE + LM-NBI + HM-NBI, and
histological examination confirms the presence of cancer
within the markings.
Unsuccessful delineation: a DL cannot be delineated,
entirely or in part, using CE, CE + LM-NBI or CE + LM-
NBI + HM-NBI, or histopathological examination of the
resected specimen reveals cancer outside the preopera-
tive markings.
Fig. 1 a. On the handle part of the scope, white marking (yellow arrow) was attached. When we press down the zoom lever (red arrow) to the point of
the marking, we can consistently fix the magnification rate as low power. When we press down the zoom lever to the bottom, we can consistently fix the
magnification rate as the highest power. b. At the low power of ME-NBI, the Line Pitch of 5–2 (white arrow) can be dissected by LM-NBI. Namely, the
resolution power was measured as 13.9 μm. c. At the resolution power of HM-NBI, the Line Pitch of 6–4 (yellow arrow) can be dissected by HM-NBI.
Namely, the resolution power was measured as 5.6 μm
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Fig. 3 Successful lesion
Fig. 2 Possible lesion
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The primary endpoint of this study was the added
benefit, as measured using the successful delineation
rate, for the delineation of gastric cancer margins using
CE + LM-NBI vs CE, and for CE + LM-NBI + HM-NBI
vs CE + LM-NBI. The secondary endpoint was the differ-
ence in the added benefit of each examination method
according to the macroscopic type of early gastric cancer.
Statistics
We derived the successful delineation rate with 95 %
confidence intervals (CI) for early gastric cancers using
each examination method, CE, CE + LM-NBI, and CE +
LM-NBI + HM-NBI. We used McNemar’s test with
Bonferroni’s multiple comparison correction to calcu-
late p values. We also performed the same calculations
for the different macroscopic types. Statistical analyses
were conducted using R3.0.1. P-values of <0.05 indi-
cated statistically significant.
Results
We resected 164 lesions using ESD in 161 patients
between July 2008 and June 2012. All lesions were re-
moved in one piece, with 161 lesions in the analysis
group after exclusion of 2 cases of undifferentiated car-
cinoma and 1 lesion that could not be assessed histologi-
cally following resection. Their clinical characteristics
were as follows: average age 71 years; 116 males and 45
females; mean lesion diameter 19.2 mm (±14.4 mm,
range 5–120 mm); macroscopic type using the Paris
classification, type 0-I 4 lesions (2.5 %), type 0-IIa 64
lesions (39.8 %), type 0-IIb 38 lesions (23.6 %), and type
0-IIc 55 lesions (34.2 %). The location of the lesion was
the upper part of the stomach in 46 cases (28.6 %), mid-
dle part in 41 (25.5 %), and lower part in 74 (46.0 %).
A flow diagram for this study is shown in Fig. 4. To
summarize the results, the lesion DL could be identified in
its entirety in 122 out of 161 lesions (75.8 %) using CE. The
DL was subsequently altered in 5 lesions using LM-NBI.
Accordingly, successful delineation was achieved using CE
in 117 (122 – 5) lesions (72.7 %, 95 % CI 68.5-79.9 %)
(Table 1). Of the 39 lesions in which the DL could not be
identified in its entirety using CE, the DL could be delin-
eated in its entirety using LM-NBI in 21 lesions, with no
alterations made subsequently using HM-NBI (Fig. 5). Suc-
cessful delineation was achieved using CE + LM-NBI in 143
lesions (88.9 %, 95 % CI 84.2-93.8 %), comprising the 117
cases of successful delineation using CE, as well as the 5
lesions whose DL was altered using LM-NBI, and the 21
lesions newly delineable using LM-NBI (117 + 5 + 21). The
successful delineation rate improved significantly with the
addition of LM-NBI (p < 0.001) (Table 1). HM-NBI exam-
ination of the 18 lesions in which the DL could not be
identified in its entirety using CE + LM-NBI enabled iden-
tification of the DL over its entire circumference in 15
lesions (Fig. 6). Accordingly, successful delineation was
achieved using CE + LM-NBI +HM-NBI in 158 lesions
(98.1 %, 95 % CI 95.8 %-100 %), a further improvement in
the successful delineation rate with CE + LM-NBI +HM-
NBI (p < 0.001 vs CE, p < 0.001 vs CE + LM-NBI). The DL
of the remaining 3 lesions could not be delineated over
their entire circumferences, and they were assessed as
Fig. 4 Flow diagram for the study
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unsuccessful delineation (Table 1). Histological examin-
ation of the resected specimens showed that all lesions
remained within the preoperative markings. In other words,
there were no cases of unsuccessful delineation in terms of
the histological findings of the resected specimens.
The results of analysis according to macroscopic type are
shown in Table 2. The successful delineation rate using CE
for protruding lesions (n = 68) was 86.8 % (95 % CI 78.8-
94.8 %), with no significant improvement in diagnostic abil-
ity seen for CE + LM-NBI (p = 0.06), but a significant added
benefit for CE + LM-NBI +HM-NBI vs CE (p = 0.02). The
successful delineation rate using CE for flat lesions (0-IIb or
0-IIb + X, n = 38) was only 34.2 % (95 % CI 19.1-49.2 %).
This improved significantly to 63.1 % (95 % CI 45.0-76.0 %)
for CE + LM-NBI (p < 0.001), and improved further to
92.1 % (95 % CI 83.5-100 %) for CE + LM-NBI +HM-NBI
(p < 0.001 vs CE, p < 0.004 vs CE + LM-NBI). The successful
delineation rate using CE for depressed lesions (n = 55) was
81.8 % (95 % CI 71.6-92.0 %), improving significantly to
98.2 % (95 % CI 94.6-100 %) for CE + LM-NBI (p = 0.02).
The successful delineation rate for CE + LM-NBI +
HM-NBI was 100 % (95 % CI 100 %), showing a
significant additive effect vs CE (p = 0.01). Accord-
ingly, for all macroscopic types HM-NBI significantly
improves the diagnostic ability of endoscopic exami-
nations, most notably in flat lesions where morpho-
logical changes are often subtle. This study also
showed that for flat lesions HM-NBI further improves
the diagnostic ability over LM-NBI.
Discussion
ESD has become the standard endoscopic treatment for
early gastric cancer, and endoscopic treatment is indi-
cated for all histologically differentiated intramucosal
cancers, regardless of size, as long as there is no ulcer-
ation [13–16]. Accordingly, accurate delineation of the
horizontal extent of gastric cancers, and minimizing the
Table 1 The number of gastric cancer with successful delineation
and successful rate by chromoendoscopy and low-power
magnifying endoscopy combined NBI and the highest-power







CE 117/161 72.7 68.5-79.9
CE + LM-NBI 143/161 88.9 84.2-93.8a
CE + LM-NBI + HM-
NBI
158/161 98.1 95.8-100a,b
a<0.05 for vs. CE; b< 0.05 for vs. CE + LM-NBI
Fig. 5 a. Chromoendoscopy (CE) findings of a gastric cancer of which margins of lateral extent cannot be clearly delineated until by Low-
power magnifying endoscopy combined NBI (LM-NBI). A demarcation line cannot be seen by CE. b. LM-NBI findings of the area indicated
by the arrow in a. A clear demarcation line can be seen. c. The highest-power magnifying endoscopy combined NBI findings of the area
indicated by the arrow in a. A clear demarcation line can be seen. d. The extent of the carcinoma (yellow lines) was reconstructed according
to the histopathological findings. The peroperative marking were clearly identified all the way around the carcinoma, as shown by black
dotted line. Therefore, this lesion had been successfully delineation by CE + LM-NBI
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extent of the resection is important in minimizing inva-
siveness for the patient, as well as making things easier
for the endoscopist. Magnifying endoscopic examination
at the highest power magnification provides the best
spatial resolution, which enables endoscopists to
visualize microvascular pattern which cannot be suffi-
ciently achieved by LM-NBI. Therefore, we can assume
that it also allows optimum accuracy for delineation of
gastric cancer margins. However, a search of the literature
failed to yield any studies of changes in diagnostic ability
for different magnification levels of ME-NBI. In this study,
the diagnostic rate for delineation of gastric cancer mar-
gins was 72.7 % for CE, 88.9 % for CE + LM-NBI, and
98.1 % for CE + LM-NBI +HM-NBI. In other words, mar-
gin delineation using HM-NBI following CE yielded the
highest diagnostic ability. This study, with strict setting of
the endoscopic magnifying ratio, for the first time demon-
strated an added benefit for the magnification level in
accurate delineation of the margins of early gastric cancers
in order to achieve successful endoscopic resection of
early gastric cancer even for 0-IIb type.
CE enhances the contrast between areas with different
topography on the mucosal surface, but some early gas-
tric cancers are completely flat (type 0-IIb), making mar-
gin delineation particularly difficult with conventional
non-magnifying endoscopy. Mishima et al. reported that
from a series of early gastric cancers resected using ESD,
the margins were unclear using CE in 48 % of type 0-IIb
lesions [17]. Furthermore, Nagahama et al. reported a
successful delineation rate of 81.8 % using CE, compared
Fig. 6 a. Chromoendoscopy (CE) findings of a gastric cancer of which margins of lateral extent cannot be clearly delineated until by the
highest-power magnifying endoscopy combined NBI (HM-NBI). A demarcation line cannot be seen by CE. b. Low-power magnifying
endoscopy combined NBI (LM-NBI) findings. A demarcation line cannot be seen by LM-NBI. c. HM-NBI findings. A clear demarcation line
can be seen by HM-NBI. d. The extent of the carcinoma (yellow lines) was reconstructed according to the histopathological findings. The
peroperative marking were clearly identified all the way around the carcinoma, as shown by black dotted line. Therefore, this lesion had been
successfully delineation by CE + LM-NBI + HM-NBI
Table 2 The successful rate in each macroscopic type by chromoendoscopy and low-power magnifying endoscopy combined NBI
and the highest-power magnifying endoscopy combined NBI
Macroscopic type CE CE + LM-NBI CE + LM-NBI + HM-NBI
Elevated (0-I, 0-IIa) 86.8 % [78.8-94.8] 97.1 % [93.1-100] 100 % [100]a
Flat (0-IIb, 0-IIb + X) 34.2 % [19.1-49.2] 63.1 % [45.0-76.0]a 92.1 % [83.5-100]a,b
Depressed (0-IIc) 81.8 % [71.6-92.0] 98.2 % [94.6-100]a 100 % [100]a
a<0.05 for vs. CE; b< 0.05 for vs. CE + LM-NBI
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to our rate of 72.7 %. A reason for this difference may
be that the Nagahama series only included 8 % of type
0-IIb lesions, less than our figure of 23.6 % for the pro-
portion of type 0-IIb lesions [4]. Our results also yielded
high successful delineation rates for CE of 86.8 % for
protruding lesions and 81.8 % for depressed lesions, but
extremely low at 34.2 % for flat lesions. ME-NBI for
delineation of the margins of type 0-IIb lesions allows us
to assess not only changes in the surface structure, but
also changes in the microvasculature, thereby improving
the diagnostic ability. Other studies of delineation of the
margins of type 0-IIb lesions using ME-NBI have re-
ported successful delineation rates of 61 % (Oyama et
al.) and 75 % (Kobayashi et al.) [18, 19]. These are simi-
lar to the successful delineation rate obtained in this
study using CE + LM-NBI, whereas the successful delin-
eation rate for CE + LM-NBI + HM-NBI of 92.1 % was
markedly higher than those in the Oyama and Kobayashi
studies. The reason for this may be that we performed
HM-NBI in all cases.
The mechanism whereby HM-NBI further improves the
diagnostic ability is likely as follows. With ME-NBI, we
diagnose gastric cancers through examination of the gastric
mucosal microvascular pattern (MVP) and microsurface
pattern (MSP). The MSP can be adequately visualized using
LM-NBI, but the resolution of approximately 14 μm for
LM-NBI is insufficient to discern mucosal microvessels
(MVs) with a minimum diameter of 8 μm. Visualization of
the MVP, a requirement for the accurate diagnosis of gas-
tric cancers, is therefore impossible with low power magni-
fication. The resolution of HM-NBI is 5.6 μm, however,
providing sufficient information to adequately assess MVs
and accurately diagnose gastric cancers [3].
The main limitation of this study was that it excluded
undifferentiated gastric cancers. Nagahama et al. per-
formed ME-NBI in all cases, reporting a lower successful
delineation rate for undifferentiated than for differentiated
gastric cancers [4]. Further studies of diagnostic ability
that include undifferentiated gastric cancers are required.
The other limitation is that for this retrospective study
have there is a possibility that we could not cancel the
carrying-over effect because we observed the target lesion
by HM-NBI following LM-NBI. In this study, we exam-
ined the added benefit of the magnification level, and did
not directly compare the diagnostic ability of LM-NBI and
HM-NBI. Further elucidation of the effect of magnifica-
tion level on diagnostic ability will require comparison of
the results of LM-NBI and HM-NBI as independent pro-
cedures. Examinations using the highest power magnifica-
tion level are technically difficult, and experience is needed
to produce clear images. Future studies of reproducibility of
results, with multiple endoscopists experienced with high-
est power magnification levels at multiple institutions,
should also be conducted.
In conclusion, ME-NBI is an extremely useful modality
for the delineation of the margins of gastric cancers, and
HM-NBI is useful for improving diagnostic performance
for endoscopic delineation of early gastric cancers, fol-
lowing CE and LM-NBI.
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